Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s13075-019-1838-6.

Title:
Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy | Arthritis Research & Therapy
Description:
Objectives Adult-onset Still’s disease (AOSD) phenotype appears to be dichotomized in systemic or chronic articular forms. As biologicals and particularly interleukin (IL)-1 and IL-6 blockers play a more and more prominent role in the treatment, their place requires clarification. This study aimed to identify factors predictive of treatment response to anakinra or tocilizumab and investigate whether the choice of biotherapy and delays in the initiation of biotherapy influenced the likelihood of steroid discontinuation. Methods A multicenter exploratory retrospective study included all patients diagnosed with AOSD and receiving biological treatments in three regional hospitals until 2018. Clinical and biological characteristics at diagnosis and treatment-related data were collected. The nonparametric Mann-Whitney test was used to perform univariate analysis for quantitative variables, and Fisher’s exact test was used for qualitative variables. Results Twenty-seven patients were included. All but one patient achieved remission with either anakinra or tocilizumab. Treatment responses depended on disease phenotype: the presence of arthritis and a chronic articular phenotype were associated with a substantial response to tocilizumab with p = 0.0009 (OR 36 [2.6–1703]) and p = 0.017 (OR 10 [1.22–92.6]), respectively, whereas the systemic form and the absence of arthritis were associated with a substantial response to anakinra with p = 0.0009 (OR 36 [2.6–1703]) and p = 0.017 (OR 10 [1.22–92.6]), respectively. Tocilizumab increased the likelihood of corticosteroid withdrawal (p = 0.029) regardless of delays in initiation or when it was initiated relative to other treatment in the overall therapeutic strategy. Conclusion This study highlights the therapeutic implications of the phenotypic dichotomy of AOSD and should help us better codify AOSD treatment.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Health & Fitness
  • Science
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

disease, patients, tocilizumab, anakinra, treatment, aosd, stills, study, article, adultonset, google, scholar, pubmed, arthritis, form, systemic, chronic, articular, biological, cas, months, response, data, phenotype, clinical, received, corticosteroids, efficacy, withdrawal, refractory, biotherapy, responded, rheumatol, diagnosis, iqr, results, presented, median, adult, likelihood, delay, clin, analysis, initiation, table, stop, fautrel, corticosteroid, therapeutic, phenotypes,

Topics {✒️}

gov/pmc/articles/pmc3390042/ saiki gov/pmc/articles/pmc4616841/ giampietro multiple drug-resistant adult-onset marie-elise truchetet gov/pmc/articles/pmc3437651/ anti-cd20 monoclonal antibody anti-extractable nuclear antigen traditional therapy-resistant adult-onset serra lópez-matencio jm increased c-reactive protein conventional treatment-refractory adult-onset nonparametric mann-whitney test thierry schaeverbeke anti-dna positive article download pdf tumor necrosis factor secure evidence-based medicine targeted therapies macrophage activation syndrome strong steroid-sparing effect clear steroid-sparing effect potential life-threatening complications ear-nose-throat il recent meta-analysis showing label anti-interleukin-1 treatments il-1r inhibitor anakinra service de rhumatologie future large-scale studies nonsteroidal anti-inflammatories reactive hemophagocytic lymphohistiocytosis randomized controlled trial privacy choices/manage cookies treating refractory adult-onset infectious-induced aosd flare anakinra-treated patients group tocilizumab-treated patients group ear-nose-throat gerfaud-valentin creative commons license recent meta-analysis suggested gonzález-gay ma clinical aosd-related characteristics anti-tnf blockers evidence-based review life-threatening conditions arthritis res ther steroid-refractory flares bordeaux teaching hospital bordeaux university hospital long-term therapy

Questions {❓}

  • How might this impact clinical practice?
  • Therapeutic innovation in adult-onset Still’s disease (and other rare inflammatory disorders): how to secure evidence-based medicine?
  • What are the new lines of research suggested by this study?
  • What is already known about this subject?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy
         description:Adult-onset Still’s disease (AOSD) phenotype appears to be dichotomized in systemic or chronic articular forms. As biologicals and particularly interleukin (IL)-1 and IL-6 blockers play a more and more prominent role in the treatment, their place requires clarification. This study aimed to identify factors predictive of treatment response to anakinra or tocilizumab and investigate whether the choice of biotherapy and delays in the initiation of biotherapy influenced the likelihood of steroid discontinuation. A multicenter exploratory retrospective study included all patients diagnosed with AOSD and receiving biological treatments in three regional hospitals until 2018. Clinical and biological characteristics at diagnosis and treatment-related data were collected. The nonparametric Mann-Whitney test was used to perform univariate analysis for quantitative variables, and Fisher’s exact test was used for qualitative variables. Twenty-seven patients were included. All but one patient achieved remission with either anakinra or tocilizumab. Treatment responses depended on disease phenotype: the presence of arthritis and a chronic articular phenotype were associated with a substantial response to tocilizumab with p = 0.0009 (OR 36 [2.6–1703]) and p = 0.017 (OR 10 [1.22–92.6]), respectively, whereas the systemic form and the absence of arthritis were associated with a substantial response to anakinra with p = 0.0009 (OR 36 [2.6–1703]) and p = 0.017 (OR 10 [1.22–92.6]), respectively. Tocilizumab increased the likelihood of corticosteroid withdrawal (p = 0.029) regardless of delays in initiation or when it was initiated relative to other treatment in the overall therapeutic strategy. This study highlights the therapeutic implications of the phenotypic dichotomy of AOSD and should help us better codify AOSD treatment.
         datePublished:2019-02-12T00:00:00Z
         dateModified:2019-02-12T00:00:00Z
         pageStart:1
         pageEnd:11
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13075-019-1838-6
         keywords:
            Adult-onset Still’s disease
            Tocilizumab
            Anakinra
            Treatment strategy
            Biologics
            Rheumatology
            Orthopedics
         image:
         isPartOf:
            name:Arthritis Research & Therapy
            issn:
               1478-6362
            volumeNumber:21
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:François Vercruysse
               url:http://orcid.org/0000-0002-0874-0308
               affiliation:
                     name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
                     address:
                        name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Thomas Barnetche
               affiliation:
                     name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
                     address:
                        name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Estibaliz Lazaro
               affiliation:
                     name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Médecine Interne
                     address:
                        name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Médecine Interne, Pessac, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Emilie Shipley
               affiliation:
                     name:Centre Hospitalier de Dax, Service de Rhumatologie
                     address:
                        name:Centre Hospitalier de Dax, Service de Rhumatologie, Dax, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:François Lifermann
               affiliation:
                     name:Centre Hospitalier de Dax, Service de Médecine Interne
                     address:
                        name:Centre Hospitalier de Dax, Service de Médecine Interne, Dax, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alexandre Balageas
               affiliation:
                     name:Centre Hospitalier de Pau, Service de Rhumatologie
                     address:
                        name:Centre Hospitalier de Pau, Service de Rhumatologie, Pau, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xavier Delbrel
               affiliation:
                     name:Centre Hospitalier de Pau, Service de Médecine Interne
                     address:
                        name:Centre Hospitalier de Pau, Service de Médecine Interne, Pau, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Bruno Fautrel
               affiliation:
                     name:Centre Hospitalier Universitaire de Paris, Hôpital Pitié Salpêtrière, Service de Rhumatologie
                     address:
                        name:Centre Hospitalier Universitaire de Paris, Hôpital Pitié Salpêtrière, Service de Rhumatologie, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Christophe Richez
               affiliation:
                     name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
                     address:
                        name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Thierry Schaeverbeke
               affiliation:
                     name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
                     address:
                        name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Marie-Elise Truchetet
               affiliation:
                     name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
                     address:
                        name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy
      description:Adult-onset Still’s disease (AOSD) phenotype appears to be dichotomized in systemic or chronic articular forms. As biologicals and particularly interleukin (IL)-1 and IL-6 blockers play a more and more prominent role in the treatment, their place requires clarification. This study aimed to identify factors predictive of treatment response to anakinra or tocilizumab and investigate whether the choice of biotherapy and delays in the initiation of biotherapy influenced the likelihood of steroid discontinuation. A multicenter exploratory retrospective study included all patients diagnosed with AOSD and receiving biological treatments in three regional hospitals until 2018. Clinical and biological characteristics at diagnosis and treatment-related data were collected. The nonparametric Mann-Whitney test was used to perform univariate analysis for quantitative variables, and Fisher’s exact test was used for qualitative variables. Twenty-seven patients were included. All but one patient achieved remission with either anakinra or tocilizumab. Treatment responses depended on disease phenotype: the presence of arthritis and a chronic articular phenotype were associated with a substantial response to tocilizumab with p = 0.0009 (OR 36 [2.6–1703]) and p = 0.017 (OR 10 [1.22–92.6]), respectively, whereas the systemic form and the absence of arthritis were associated with a substantial response to anakinra with p = 0.0009 (OR 36 [2.6–1703]) and p = 0.017 (OR 10 [1.22–92.6]), respectively. Tocilizumab increased the likelihood of corticosteroid withdrawal (p = 0.029) regardless of delays in initiation or when it was initiated relative to other treatment in the overall therapeutic strategy. This study highlights the therapeutic implications of the phenotypic dichotomy of AOSD and should help us better codify AOSD treatment.
      datePublished:2019-02-12T00:00:00Z
      dateModified:2019-02-12T00:00:00Z
      pageStart:1
      pageEnd:11
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13075-019-1838-6
      keywords:
         Adult-onset Still’s disease
         Tocilizumab
         Anakinra
         Treatment strategy
         Biologics
         Rheumatology
         Orthopedics
      image:
      isPartOf:
         name:Arthritis Research & Therapy
         issn:
            1478-6362
         volumeNumber:21
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:François Vercruysse
            url:http://orcid.org/0000-0002-0874-0308
            affiliation:
                  name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
                  address:
                     name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Thomas Barnetche
            affiliation:
                  name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
                  address:
                     name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Estibaliz Lazaro
            affiliation:
                  name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Médecine Interne
                  address:
                     name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Médecine Interne, Pessac, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Emilie Shipley
            affiliation:
                  name:Centre Hospitalier de Dax, Service de Rhumatologie
                  address:
                     name:Centre Hospitalier de Dax, Service de Rhumatologie, Dax, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:François Lifermann
            affiliation:
                  name:Centre Hospitalier de Dax, Service de Médecine Interne
                  address:
                     name:Centre Hospitalier de Dax, Service de Médecine Interne, Dax, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alexandre Balageas
            affiliation:
                  name:Centre Hospitalier de Pau, Service de Rhumatologie
                  address:
                     name:Centre Hospitalier de Pau, Service de Rhumatologie, Pau, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xavier Delbrel
            affiliation:
                  name:Centre Hospitalier de Pau, Service de Médecine Interne
                  address:
                     name:Centre Hospitalier de Pau, Service de Médecine Interne, Pau, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bruno Fautrel
            affiliation:
                  name:Centre Hospitalier Universitaire de Paris, Hôpital Pitié Salpêtrière, Service de Rhumatologie
                  address:
                     name:Centre Hospitalier Universitaire de Paris, Hôpital Pitié Salpêtrière, Service de Rhumatologie, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Christophe Richez
            affiliation:
                  name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
                  address:
                     name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Thierry Schaeverbeke
            affiliation:
                  name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
                  address:
                     name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Marie-Elise Truchetet
            affiliation:
                  name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
                  address:
                     name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Arthritis Research & Therapy
      issn:
         1478-6362
      volumeNumber:21
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
      address:
         name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
         type:PostalAddress
      name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
      address:
         name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
         type:PostalAddress
      name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Médecine Interne
      address:
         name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Médecine Interne, Pessac, France
         type:PostalAddress
      name:Centre Hospitalier de Dax, Service de Rhumatologie
      address:
         name:Centre Hospitalier de Dax, Service de Rhumatologie, Dax, France
         type:PostalAddress
      name:Centre Hospitalier de Dax, Service de Médecine Interne
      address:
         name:Centre Hospitalier de Dax, Service de Médecine Interne, Dax, France
         type:PostalAddress
      name:Centre Hospitalier de Pau, Service de Rhumatologie
      address:
         name:Centre Hospitalier de Pau, Service de Rhumatologie, Pau, France
         type:PostalAddress
      name:Centre Hospitalier de Pau, Service de Médecine Interne
      address:
         name:Centre Hospitalier de Pau, Service de Médecine Interne, Pau, France
         type:PostalAddress
      name:Centre Hospitalier Universitaire de Paris, Hôpital Pitié Salpêtrière, Service de Rhumatologie
      address:
         name:Centre Hospitalier Universitaire de Paris, Hôpital Pitié Salpêtrière, Service de Rhumatologie, Paris, France
         type:PostalAddress
      name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
      address:
         name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
         type:PostalAddress
      name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
      address:
         name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
         type:PostalAddress
      name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
      address:
         name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:François Vercruysse
      url:http://orcid.org/0000-0002-0874-0308
      affiliation:
            name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
            address:
               name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Thomas Barnetche
      affiliation:
            name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
            address:
               name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
               type:PostalAddress
            type:Organization
      name:Estibaliz Lazaro
      affiliation:
            name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Médecine Interne
            address:
               name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Médecine Interne, Pessac, France
               type:PostalAddress
            type:Organization
      name:Emilie Shipley
      affiliation:
            name:Centre Hospitalier de Dax, Service de Rhumatologie
            address:
               name:Centre Hospitalier de Dax, Service de Rhumatologie, Dax, France
               type:PostalAddress
            type:Organization
      name:François Lifermann
      affiliation:
            name:Centre Hospitalier de Dax, Service de Médecine Interne
            address:
               name:Centre Hospitalier de Dax, Service de Médecine Interne, Dax, France
               type:PostalAddress
            type:Organization
      name:Alexandre Balageas
      affiliation:
            name:Centre Hospitalier de Pau, Service de Rhumatologie
            address:
               name:Centre Hospitalier de Pau, Service de Rhumatologie, Pau, France
               type:PostalAddress
            type:Organization
      name:Xavier Delbrel
      affiliation:
            name:Centre Hospitalier de Pau, Service de Médecine Interne
            address:
               name:Centre Hospitalier de Pau, Service de Médecine Interne, Pau, France
               type:PostalAddress
            type:Organization
      name:Bruno Fautrel
      affiliation:
            name:Centre Hospitalier Universitaire de Paris, Hôpital Pitié Salpêtrière, Service de Rhumatologie
            address:
               name:Centre Hospitalier Universitaire de Paris, Hôpital Pitié Salpêtrière, Service de Rhumatologie, Paris, France
               type:PostalAddress
            type:Organization
      name:Christophe Richez
      affiliation:
            name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
            address:
               name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
               type:PostalAddress
            type:Organization
      name:Thierry Schaeverbeke
      affiliation:
            name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
            address:
               name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
               type:PostalAddress
            type:Organization
      name:Marie-Elise Truchetet
      affiliation:
            name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
            address:
               name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
      name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
      name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Médecine Interne, Pessac, France
      name:Centre Hospitalier de Dax, Service de Rhumatologie, Dax, France
      name:Centre Hospitalier de Dax, Service de Médecine Interne, Dax, France
      name:Centre Hospitalier de Pau, Service de Rhumatologie, Pau, France
      name:Centre Hospitalier de Pau, Service de Médecine Interne, Pau, France
      name:Centre Hospitalier Universitaire de Paris, Hôpital Pitié Salpêtrière, Service de Rhumatologie, Paris, France
      name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
      name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
      name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France

External Links {🔗}(169)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.21s.